Press Room
One Drug to Shrink All Tumors?
03/30/2012
The treatment, an antibody that blocks a "do not eat" signal normally displayed on tumor cells, coaxes the immune system to destroy the cancer cells.
Kidney cancer cases at record high
03/30/2012
In 1975, 2,953 people were diagnosed with kidney cancer in Britain. Latest figures show there were 9,042 cases in 2009, up from 8,848 in 2008.
Kidney cancer subtype study finds low recurrence and cancer death rates
03/30/2012
Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI.
Cancer research targets a key cell protein
03/28/2012
The Stanford team examined cancer cells removed from patients with a variety of types of solid tumors. They found that CD47 studded the membranes of almost all of the cancer cells in their sample, suggesting that it is a molecule common to all cancers.
AACR Annual Meeting: Various Abstracts
03/28/2012
Opinion: These pre-clinical findings could provide the thesis for a potential positive outcome in the current Phase 1 study "A Phase I Study of Ridaforolimus and Vorinostat in Patients With Advanced Renal Cell Carcinoma (RCC)...
Kidney Cancer Association App for 3rd Gen iPad
03/28/2012
Users of smartphone technology get access to the most current information about renal cancers.
Native nephrectomy for renal cell carcinoma in transplant recipients
03/28/2012
Dialysis patients and transplant recipients, especially those with acquired cystic kidney disease, are at increased risk for renal cell carcinoma (RCC). We report our experience in 15 posttransplant patients who underwent nephrectomy for renal masses.
Targeted therapies for non-clear renal cell carcinoma
03/28/2012
The treatment of advanced and metastatic kidney cancer has been revolutionized by the development of targeted systemic therapies. Despite the growing number of available agents approved for use against clear cell renal cell carcinoma, patients with non-clear histologies, constituting approximately 1 in 4 cases of kidney cancer, have not received the same attention.
UGA Researchers Kill Neck and Head Cancer Cells
03/28/2012
Nanoparticles and magnetic fields team up to attack tumor cells in mice.
Heart-damaging side effects of cancer drugs under-reported
03/27/2012
The under-reporting of the possible side effects of heart damage from cancer drugs puts patients at an increased risk for heart failure, according to two researchers at the Stanford University School of Medicine.
News Feed| Powered by NeonCRM |